entertainment -WSS

entertainment

author：comprehensive 2025-09-29 14:00:23 - browse：9

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Medicare has a new plan to address drug shortages

leisure time

WSS

Why workplace violence is so common in health care

At Orexo, a ‘turning point’ for everything but digital health

Group opposing PBM reform sets lobbying record

AI can’t replace a physician’s gut feeling

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Trump Jan. 6 attorney John Lauro is ex

leisure time

entertainment

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Drug repurposing or repositioning? The language matters

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Walensky prepares to leave CDC — and Congress — behind

The UK government moves asylum

Trump demands the U.S. pay no more for drugs than other countries … again

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

23andMe had bad news about my health. I wish a person had delivered it

Cosmetics set for new safety regulation. Why the industry is on board

Wikipedia

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Sanofi seeks simpler, safer CRISPR sickle cell cure

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Medicare to cover more brain scans for Alzheimer’s patients

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

The UK government moves asylum

leisure time

focus

knowledge

focus